296 related articles for article (PubMed ID: 3389208)
21. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
Berkowicz A; Kappelgaard E; Petersen J; Nielsen H; Ingemann-Hansen T; Halkjaer-Kristensen J; Sørensen H
Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
[TBL] [Abstract][Full Text] [Related]
22. Humoral immune system activity in inflammatory bowel disease.
Teisberg P; Gjone E
Scand J Gastroenterol; 1975; 10(5):545-9. PubMed ID: 1171519
[TBL] [Abstract][Full Text] [Related]
23. Complement activation in fetuses: assessment by the levels of complement components and split products in cord blood.
Miyano A; Nakayama M; Fujita T; Kitajima H; Imai S; Shimizu A
Diagn Clin Immunol; 1987; 5(2):86-90. PubMed ID: 3497734
[TBL] [Abstract][Full Text] [Related]
24. Studies on the haemolytic activity of circulating C1q-C3/C4 complexes.
Wouters D; Brouwer MC; Daha MR; Hack CE
Mol Immunol; 2008 Apr; 45(7):1893-9. PubMed ID: 18054386
[TBL] [Abstract][Full Text] [Related]
25. Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.
Senaldi G; Makinde VA; Vergani D; Isenberg DA
Ann Rheum Dis; 1988 Nov; 47(11):913-7. PubMed ID: 3264693
[TBL] [Abstract][Full Text] [Related]
26. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation.
Teisner B; Brandslund I; Grunnet N; Hansen LK; Thellesen J; Svehag SE
J Clin Lab Immunol; 1983 Oct; 12(2):63-7. PubMed ID: 6606048
[TBL] [Abstract][Full Text] [Related]
27. Classical and alternative complement pathway activation in paracoccidioidomycosis.
de Messias IT; Mohren D
J Investig Allergol Clin Immunol; 1994; 4(2):91-5. PubMed ID: 7921333
[TBL] [Abstract][Full Text] [Related]
28. Reduction of complement activation in rheumatoid arthritis by steroid treatment.
Ernst E; Espersen GT; Andersen MV
Int J Tissue React; 1990; 12(2):77-9. PubMed ID: 2170287
[TBL] [Abstract][Full Text] [Related]
29. Infliximab treatment reduces complement activation in patients with rheumatoid arthritis.
Familian A; Voskuyl AE; van Mierlo GJ; Heijst HA; Twisk JW; Dijkmans BA; Hack CE
Ann Rheum Dis; 2005 Jul; 64(7):1003-8. PubMed ID: 15958758
[TBL] [Abstract][Full Text] [Related]
30. Circulating C3, C4, and C3 split products (C3c and C3d) during normal pregnancy.
Teisner B; Hau J; Tucker M; Lahood J; Grudzinskas JG
Am J Reprod Immunol (1980); 1982 Dec; 2(6):309-11. PubMed ID: 6984294
[TBL] [Abstract][Full Text] [Related]
31. Sensitivity and specificity of plasma and urine complement split products as indicators of lupus disease activity.
Manzi S; Rairie JE; Carpenter AB; Kelly RH; Jagarlapudi SP; Sereika SM; Medsger TA; Ramsey-Goldman R
Arthritis Rheum; 1996 Jul; 39(7):1178-88. PubMed ID: 8670328
[TBL] [Abstract][Full Text] [Related]
32. [Complement (C3 and C4) in patients with rheumatoid arthritis during 6 months of treatment with gold salts].
Vlak T; Jajić I
Reumatizam; 1992; 39(1):7-10. PubMed ID: 1366144
[TBL] [Abstract][Full Text] [Related]
33. Complement activation during cardiopulmonary bypass in infants and children. Relation to postoperative multiple system organ failure.
Seghaye MC; Duchateau J; Grabitz RG; Faymonville ML; Messmer BJ; Buro-Rathsmann K; von Bernuth G
J Thorac Cardiovasc Surg; 1993 Dec; 106(6):978-87. PubMed ID: 8246580
[TBL] [Abstract][Full Text] [Related]
34. Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.
Davies ET; Nasaruddin BA; Alhaq A; Senaldi G; Vergani D
J Clin Pathol; 1988 Feb; 41(2):143-7. PubMed ID: 3350977
[TBL] [Abstract][Full Text] [Related]
35. [Study of C3 and C4 complement components of synovial fluids in connective tissue diseases (author's transl)].
Böhm U; Merétey K; Falus A; Jancsó A; Bozsóky S
Allerg Immunol (Leipz); 1978; 24(3):167-74. PubMed ID: 152571
[TBL] [Abstract][Full Text] [Related]
36. [Complement (C3)-activating material in synovial fluid from patients with rheumatoid arthritis].
Stojan B
Z Rheumatol; 1981; 40(5):208-12. PubMed ID: 6914866
[TBL] [Abstract][Full Text] [Related]
37. Complement activation in acute coronary syndromes.
Iltumur K; Karabulut A; Toprak G; Toprak N
APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
[TBL] [Abstract][Full Text] [Related]
38. [CH50, C3 and C4 in the serum and synovial fluid of rheumatoid arthritis patients].
Sheĭtanov I; Nikolov K; Petrova P
Vutr Boles; 1987; 26(4):66-70. PubMed ID: 3499707
[TBL] [Abstract][Full Text] [Related]
39. Activation of the classical complement pathway in spontaneous bacterial peritonitis.
Bird G; Senaldi G; Panos M; Rolando N; Alexander G; Vergani D; Williams R
Gut; 1992 Mar; 33(3):307-11. PubMed ID: 1568647
[TBL] [Abstract][Full Text] [Related]
40. A novel ELISA for the assessment of classical pathway of complement activation in vivo by measurement of C4-C3 complexes.
Zwirner J; Dobos G; Götze O
J Immunol Methods; 1995 Oct; 186(1):55-63. PubMed ID: 7561148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]